NFL Biosciences SA (ALNFL) Stock Price & Analysis

1 Followers

ALNFL Stock Chart & Stats

€0.40€0.01(1.53%)

At close: Nov 11 5:30 PM GMT+1

Day’s Range: EUR 0.39 - EUR 0.40
52-Week Range: EUR 0.34 - EUR 1.85
Previous Close: EUR 0.39
Volume: N/A
Average Volume (3M): 72.28K
Market Cap: EUR 4.93M
Enterprise Value: EUR 11.98M
Total Cash (Recent Filing): EUR 2.68M
Total Debt (Recent Filing): EUR 3.27M
Price to Earnings (P/E): ―
Beta: 0.96
Next Earnings: Mar 29, 2027 (Est.)
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: N/A

NFL Biosciences SA News

NFL Biosciences Seeks Global Partner to Advance Smoking Cessation Pipeline

The latest update is out from NFL Biosciences SA ( ($FR:ALNFL) ). NFL Biosciences, a French biopharmaceutical company specializing in immunotherapies for smoking and nicotine cessation, is advancing a portfolio

1w ago82F ALNFL

NFL Biosciences Advances Dual Immunotherapy Programs for Smoking Cessation

NFL Biosciences SA ( ($FR:ALNFL) ) just unveiled an announcement. NFL Biosciences reported progress across its smoking-cessation pipeline, highlighting biomarker-supported Phase 2 data for NFL-101 and preparations for Phase 3

3w ago82F ALNFL

NFL Biosciences Wins Green Light for Phase 2 TONIC Trial of Smoking Cessation Immunotherapy NFL-102

An announcement from NFL Biosciences SA ( ($FR:ALNFL) ) is now available. NFL Biosciences has secured approvals from French health authorities ANSM and CPP to launch its Phase 2 TONIC

3w ago82F ALNFL

NFL Biosciences advances smoking-cessation immunotherapies with new clinical and mechanistic milestones

NFL Biosciences SA ( ($FR:ALNFL) ) has shared an update. NFL Biosciences is advancing a portfolio of tobacco leaf-derived immunotherapies for smoking and nicotine dependence, centered on its lead candidates

1M ago82F ALNFL

NFL Biosciences to Present NFL-101 Biomarker Data at Major Tobacco Control Conferences

NFL Biosciences SA ( ($FR:ALNFL) ) has shared an announcement. NFL Biosciences SA announced that a scientific communication on a predictive biomarker for its smoking cessation candidate NFL-101 has been

2M ago82F ALNFL

NFL Biosciences Streamlines Phase 2 TONIC Trial for Botanical Smoking Cessation Drug NFL-102

An announcement from NFL Biosciences SA ( ($FR:ALNFL) ) is now available. NFL Biosciences has submitted its TONIC Phase 2 clinical trial protocol to French regulators ANSM and CPP, marking

3M ago82F ALNFL

NFL Biosciences Unveils 2025 Financial Agenda

An announcement from NFL Biosciences SA ( ($FR:ALNFL) ) is now available. NFL Biosciences has announced its financial agenda for 2025, detailing key dates for the release of its annual

1y ago82F ALNFL

NFL Biosciences Confirms NFL-101’s Superior Safety in New Study

The latest announcement is out from NFL Biosciences SA ( ($FR:ALNFL) ). NFL Biosciences announced positive results from a toxicity study of its drug NFL-101, which is used for treating

1y ago82F ALNFL

NFL Biosciences Advancing Addiction Treatments

NFL Biosciences SA (FR:ALNFL) has released an update. NFL Biosciences SA has made significant progress in the first half of 2024 with its smoking cessation drug NFL-101, successfully completing Phase

2y ago82F ALNFL

ALNFL FAQ

What was NFL Biosciences SA’s price range in the past 12 months?

NFL Biosciences SA lowest stock price was €0.34 and its highest was €1.85 in the past 12 months.

What is NFL Biosciences SA’s market cap?

NFL Biosciences SA’s market cap is €4.93M.

When is NFL Biosciences SA’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were NFL Biosciences SA’s earnings last quarter?

NFL Biosciences SA released its earnings results on Oct 22, 2026. The company reported -€0.117 earnings per share for the quarter.

Is NFL Biosciences SA overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does NFL Biosciences SA pay dividends?

NFL Biosciences SA does not currently pay dividends.

What is NFL Biosciences SA’s EPS estimate?

NFL Biosciences SA’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does NFL Biosciences SA have?

NFL Biosciences SA has 12,672,242 shares outstanding.

What happened to NFL Biosciences SA’s price movement after its last earnings report?

NFL Biosciences SA reported an EPS of -€0.117 in its last earnings report. Following the earnings report the stock price went up 1.818%.

Which hedge fund is a major shareholder of NFL Biosciences SA?

Currently, no hedge funds are holding shares in FR:ALNFL

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description